All-Cause Mortality and Liver-Related Outcomes Following Successful Antiviral Treatment for Chronic Hepatitis C

@article{Dieperink2014AllCauseMA,
  title={All-Cause Mortality and Liver-Related Outcomes Following Successful Antiviral Treatment for Chronic Hepatitis C},
  author={Eric W Dieperink and Christine Pocha and Paul D. Thuras and Astrid Knott and Samuel Colton and Samuel B. Ho},
  journal={Digestive Diseases and Sciences},
  year={2014},
  volume={59},
  pages={872-880}
}
Antiviral therapy for the hepatitis C virus (HCV) reduces all-cause and liver-related morbidity and mortality. Few studies are available from populations with multiple medical and psychiatric comorbidities where the impact of successful antiviral therapy might be limited. The purpose of this study was to determine the effect of sustained virologic response (SVR) on all-cause and liver-related mortality in a cohort of HCV patients treated in an integrated hepatitis/mental health clinic. This was… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis C.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco • 2017
View 1 Excerpt

Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2016

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Sofosbuvir for previously untreated chronic hepatitis C infection.

The New England journal of medicine • 2013
View 1 Excerpt

Multisite randomized trial of an Integrated Care ( IC ) model for HCV patients with psychiatric and substance use comorbidities : final results of impact on treatment initiation

SB Ho, EJ Groessl, N Brau
Hepatology • 2012

Multisite randomized trial of an Integrated Care (IC) model for HCV patients with psychiatric and substance use co-morbidities: final results of impact on treatment

SB Ho, EJ Groessl, N Brau
initiation. Hepatology • 2012
View 1 Excerpt

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2011

Similar Papers

Loading similar papers…